Document is current
Any future updates will be listed below
-
Authors
Mirzai, Saeid
Persits, Ian
Martens, Pieter
Estep, Jerry D.
Wilson Tang, W. H.
Chen, Po-Hao
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32HL076132)
National Institutes of Health (R01HL146754)
Cleveland Clinic Philanthropy Institute’s Caregiver Catalyst Grant
Cleveland Clinic Musculoskeletal Research Center’s Pilot Project Program Grant
Belgian American Educational Foundation
Frans Van de Werf Fund
- License Information
-
More Information
Article History
Received: 13 March 2024
Accepted: 22 June 2024
First Online: 4 July 2024
Declarations
:
: The Cleveland Clinic Institutional Review Board approved this study. Given the retrospective design, the need for written informed consent was waived.
: Dr. Martens has received consultancy fees from AstraZeneca, Abbott, Bayer, Boehringer-Ingelheim, Daiichi Sankyo, Novartis, Novo Nordisk, and Vifor Pharma. Dr. Estep is a consultant for Abbott, Getinge, and BioVentrix. Dr. Tang serves as a consultant to Sequana Medical, Cardiol Therapeutics, Genomics plc, Renovacor, Zehna Therapeutics, Boston Scientific, Kiniksa Pharmaceuticals, WhiteSwell, CardiaTec Biosciences, Intellia Therapeutics, and received honoraria from Springer, Belvoir Media Group, and American Board of Internal Medicine - all unrelated to the topic of study. All other authors have no relationships to disclose.
